Purchase Order 75N92022P00330
Award Date
9/15/22
Potential Completion Date
11/30/22
Potential Value
$198K
Funding Federal Agency
National Human Genome Research Institute
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $178,500.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, for the purchase of a NextSeq 500 sequencing system. This award supports the NIH's research and diagnostic needs, as Illumina has provided a range of sequencing systems and consumables to HHS, the Centers for Disease Control and Prevention, the Department of...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $224,400.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The award is for the provision of a NextSeq 550 Sequencing System with a trade-in of a HiSeq 500 system. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $10,856.27 firm fixed price delivery order to Illumina, Inc. for goods and services to support genomic sequencing and analysis. As the sole manufacturer of the sequencing instruments in use, Illumina will provide reagents, consumables and other supplies under the delivery order citing its proprietary technology. The place of performance is the agency's location in...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $516,120.00 firm fixed price purchase order to Illumina, Inc. to procure two NextSeq 550 DNA sequencers. The award does not include any set-aside designation. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, has previously provided sequencing systems, reagents, and support services to federal agencies like the NIH, CDC, USDA, and VA...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of genetic sequencing systems and related products, for the delivery of an Illumina NextSeq 550 Sequencing System. The potential value of the award is $224,400.00. No set-aside provisions were used. The award was made under a special notice solicitation for an Illumina HiSeq 2500 Sequencer. Illumina has...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and related products, to provide a NextSeq 2000 sequencing system. The potential value of the contract is $290,700.00. There was no set-aside designation for this award. Illumina has previously received prime contract awards from federal agencies like the National...
This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $149,987.33 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with related consumables, support, and maintenance services. This award does not have a small business set-aside designation....
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $94,792 firm fixed price delivery order to Illumina, Inc. of Bethesda, Maryland. The delivery order was issued under an existing indefinite delivery contract with the manufacturer to supply various sequencing systems, reagents, and services in support of genomic research. As the sole provider of the sequencing platforms used at the agency, Illumina will deliver proprietary...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $1,243,477.63 contract is for the provision of Illumina's proprietary NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying consumables and support services to support the agency's genomic research...